Skip to main content
Home
  • About
    • About the Navigator
    • Navigator FAQs
  • Guides
    • For Patients and Caregivers
    • For Physicians and Healthcare Providers
    • For Companies and Sponsors
  • Company Directory
    • View Company Directory
    • Submit Company Information
  • Resources
  • Expanded Access eRequest
  • facebook
  • twitter
  • linkedin
  • youtube
Home
  • About
    • About the Navigator
    • Navigator FAQs
  • Guides
    • For Patients and Caregivers
    • For Physicians and Healthcare Providers
    • For Companies and Sponsors
  • Company Directory
    • View Company Directory
    • Submit Company Information
  • Resources
  • Expanded Access eRequest

Covid-19 Vaccination in Adolescents and Children

  • Read more about Covid-19 Vaccination in Adolescents and Children

Epidemiological Monitoring of COVID-19 Patients Hospitalized on Reunion Island

  • Read more about Epidemiological Monitoring of COVID-19 Patients Hospitalized on Reunion Island

Randomised Clinical Trial to Evaluate the Efficacy of an Online Cognitive Rehabilitation Programme (COPERIA-COG) for Patients With Persistent COVID-19

  • Read more about Randomised Clinical Trial to Evaluate the Efficacy of an Online Cognitive Rehabilitation Programme (COPERIA-COG) for Patients With Persistent COVID-19

Low-Dose Radiation Therapy for Severe COVID-19 Pneumonia

  • Read more about Low-Dose Radiation Therapy for Severe COVID-19 Pneumonia

SHEN211 Tablets for the Treatment of Mild and Moderate Novel Corona Virus Infections (COVID-19)

  • Read more about SHEN211 Tablets for the Treatment of Mild and Moderate Novel Corona Virus Infections (COVID-19)

Effect of a Health Pathway for People With Persistent Symptoms Covid-19

  • Read more about Effect of a Health Pathway for People With Persistent Symptoms Covid-19

Randomized, Single-blinded, Multicenter Trial Comparing the Immune Response to a 2nd Booster Dose of COVID-19 mRNA Vaccine (Pfizer-BioNTech) or Sanofi /GSK B.1.351 Adjuvanted Vaccine in Adults

  • Read more about Randomized, Single-blinded, Multicenter Trial Comparing the Immune Response to a 2nd Booster Dose of COVID-19 mRNA Vaccine (Pfizer-BioNTech) or Sanofi /GSK B.1.351 Adjuvanted Vaccine in Adults

Pulmonary and Extrapulmonary Impacts of COVID-19 on Young Adults

  • Read more about Pulmonary and Extrapulmonary Impacts of COVID-19 on Young Adults

Extrapulmonary Presentations of COVID-19 Patients

  • Read more about Extrapulmonary Presentations of COVID-19 Patients

INAVAC Vaccine Phase III (Immunobridging Study) in Healthy Population Aged 12 to 17 Years Old

  • Read more about INAVAC Vaccine Phase III (Immunobridging Study) in Healthy Population Aged 12 to 17 Years Old

Pagination

  • First page « First
  • Previous page ‹ Previous
  • …
  • Page 92
  • Page 93
  • Page 94
  • Page 95
  • Current page 96
  • Page 97
  • Page 98
  • Page 99
  • Page 100
  • …
  • Next page Next ›
  • Last page Last »
Subscribe to

Subscribe for updates from the Reagan-Udall Foundation for the FDA

Subscribe
(202) 849 - 2075
1333 New Hampshire Ave, NW
Suite 420
Washington, DC 20036
navigator@reaganudall.org
  • facebook
  • twitter
  • linkedin
  • youtube

© Reagan-Udall Foundation for the FDA
© Reagan-Udall Foundation for the FDA